Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Johnson & Johnson
Johnson & Johnson
Page 12 of 18
Health
J&J pauses COVID-19 vaccine trial after participant falls ill
By
Trading Desk
October 13, 2020
Health
Which COVID-19 vaccine works best? A new lab network promises an answer
By
Research Team
October 6, 2020
Conferences
How 3 of biopharma’s most powerful women are building public trust during COVID
By
Staff Writer
September 29, 2020
Health
Under fire, AstraZeneca CEO defends transparency of COVID-19 vaccine trials
By
Trading Desk
September 24, 2020
Health
Oxford’s COVID vaccine deal with AstraZeneca raises concerns about access and pricing
By
Crypto Correspondent
August 24, 2020
Tech
Johnson & Johnson just invested in a telemedicine startup. Here’s why
By
Blockchain Reporter
August 14, 2020
Health
Johnson & Johnson antidepressant spray approved for treating those at risk of suicide
By
Cynthia Koons
and
Bloomberg
August 3, 2020
Newsletters
Johnson & Johnson’s CEO on building trust for a coronavirus vaccine
By
Crypto Correspondent
July 9, 2020
Newsletters
J&J’s CEO says creating a vaccine is only ‘part of the puzzle’
By
Katherine Dunn
and
Alan Murray
July 9, 2020
Health
5 companies to keep an eye on following the world’s largest cancer conference
By
Staff Writer
June 3, 2020
Newsletters
Big pharma’s big chance
By
Katherine Dunn
and
Alan Murray
April 3, 2020
Newsletters
Johnson & Johnson CEO on the race to make a coronavirus vaccine
By
Katherine Dunn
and
Alan Murray
March 31, 2020
Newsletters
J&J’s coronavirus vaccine could hit the market by 2021
By
Investment Desk
March 30, 2020
Health
Johnson & Johnson hopes to have its promising coronavirus vaccine approved by early 2021
By
Contributing Writer
March 30, 2020
Newsletters
Apple and Johnson & Johnson team up on heart study
By
Blockchain Reporter
February 26, 2020
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Staff Writer
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Blockchain Reporter
Economy
Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
By
Editorial Team